1/26/2024 | 3002120005 | HUMAN BIOLOGICAL MATERIALS FOR LABORATORY STUDIES DURING A CLINICAL STUDY OF THE DRUG "SUPECT (RADOTINIB HYDROCHLORIDE)". ARE TRANSPORTED IN A DISPOSABLE THERMAL CONTAINER WITH DRY ICE. | XXXXXXXXXX | 2 | N/A | 0 | South Korea | MOSCOW |
1/12/2024 | 3002120005 | HUMAN BIOLOGICAL MATERIALS; FOR LABORATORY STUDIES DURING A CLINICAL STUDY OF THE DRUG "SUPECT (RADOTINIB HYDROCHLORIDE)". TRANSPORTED IN A DISPOSABLE THERMAL CONTAINER WITH DRY ICE. | XXXXXXXXXX | 2 | N/A | 0 | South Korea | MOSCOW |
11/24/2023 | 3002120005 | BLOOD FRACTIONS (BIOLOGICAL SAMPLES) IN TEST TUBE, FOR LABORATORY STUDIES OF BIOLOGICAL MATERIALS. OBTAINED DURING CLINICAL TESTS | XXXXXXXXXX | 0 | 0 | 2149.87 | India | UNkNOwN |
10/19/2023 | 3002120005 | BLOOD FRACTIONS (BIOLOGICAL SAMPLES) IN TEST TUBE, FOR LABORATORY STUDIES OF BIOLOGICAL MATERIALS OBTAINED DURING CLINICAL TRIALS | XXXXXXXXXX | 0 | 0 | 2080.63 | India | UNkNOwN |
10/4/2023 | 3002120005 | HUMAN BIOLOGICAL MATERIALS OBTAINED DURING A CLINICAL STUDY OF THE DRUG "MAVORIXAFOR (X4P-001)" FOR MEDICAL | XXXXXXXXXX | 0 | 0 | 0.81 | Belgium | MOSCOW |
9/5/2023 | 3002120005 | FROZEN BLOOD PLASMA SAMPLES (BIOLOGICAL SAMPLES) IN 2 ML TUBES, FOR LABORATORY STUDIES OF BIOLOGICAL MATERIALS. | XXXXXXXXXX | 0 | 0 | 272.2 | Hungary | UNkNOwN |
8/22/2023 | 3002120005 | BIOLOGICAL PREPARATIONS (HUMAN ORIGIN) FOR SCIENTIFIC RESEARCH PURPOSES. HAVE PASSED AN ACID CLEANING STAGE THAT ELIMINATES THE PRESENCE OF VIRUSES | XXXXXXXXXX | 0 | 0 | 1111.33 | United Kingdom | KIDLINGTON |
8/7/2023 | 3002120005 | BLOOD FRACTIONS (BIOLOGICAL SAMPLES) IN TEST TUBE. FOR CONDUCTING LABORATORY STUDIES OF BIOLOGICAL MATERIALS OBTAINED DURING CLINICAL TREATMENTS | XXXXXXXXXX | 0 | 0 | 989.01 | India | UNkNOwN |
7/26/2023 | 3002120005 | FROZEN BLOOD PLASMA SAMPLES (BIOLOGICAL SAMPLES) IN 2 ML TUBE. FOR CONDUCTING LABORATORY STUDIES OF BIOLOGICAL MATERIALS, | XXXXXXXXXX | 0 | 0 | 326.77 | Hungary | UNkNOwN |
7/13/2023 | 3002120005 | HUMAN BIOLOGICAL MATERIALS FOR LABORATORY STUDIES DURING A CLINICAL STUDY OF THE DRUG "SUPECT ( | XXXXXXXXXX | 0 | 0 | 0.22 | South Korea | MOSCOW |